Sarfaraz Memon, MD
Interventional Cardiology · Hartford, CTNPI 1962727982
Payments from drug & device makers
What this record shows
This record is dominated by grants: $22,055 of the $30,473 with a category attached, or 72.4%. Medtronic accounts for 87.6% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2022 at $22,594 and has fallen 85.4% since, to $3,307 in 2025. Among interventional cardiology clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 155 payments — averaging $196.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$27K
- Edwards Lifesciences$2K
- Shockwave Medical, Inc$316
- Astellas Pharma US Inc$252
- Cardiovascular Systems Inc.$229
- Abbott$194
- plus $665 from 14 others
Across 1 payment — averaging $5250.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$5K
What the payments were for
- Grants$22,05572%
- Travel & lodging$2,3548%
- Food & beverage$5,66719%
- Education$3971%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 88 | $26,691 |
| Edwards Lifesciences | 23 | $2,127 |
| Shockwave Medical, Inc | 3 | $316 |
| Astellas Pharma US Inc | 3 | $252 |
| Cardiovascular Systems Inc. | 4 | $229 |
| Abbott | 4 | $194 |
| Boston Scientific | 4 | $115 |
| AstraZeneca | 7 | $101 |
| Bard Peripheral Vascular, Inc. | 1 | $76 |
| E.r. Squibb & Sons, L.L.C. | 3 | $70 |
| Amgen | 3 | $52 |
| Inari Medical, Inc. | 1 | $47 |
| Chiesi USA, Inc. | 2 | $43 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $40 |
| Johnson & Johnson | 2 | $35 |
| Novartis | 1 | $22 |
| Penumbra, Inc. | 1 | $20 |
| Lantheus Medical Imaging, Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| Opsens Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$30,473 in reported general payments places this provider in the 90th percentile of 73 interventional cardiology providers in Connecticut.
See all interventional cardiology providers in Connecticut →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Hartford
- Craig ThompsonHartford$222K
- Abdul QaziHartford$38K
- Boskey PatelHartford$20K
- Joseph IngrassiaHartford$16K
- Talhat AzemiHartford$12K
- Bryan PiccirilloHartford$12K
- Immad SadiqHartford$9K
- Asad RizviHartford$5K
- Daniel FramHartford$3K
- Arslan MasoodHartford$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.